A Study of MIRCERA for the Intrapetient Variability of Hemoglobin Levels in Patients With Chronic Renal Anemia (RIVAL)

An Observational Study of Hemoglobin Stability in Chronic Kidney Disease Patients on Dialysis Treated With Mircera (Methoxy Polyethylene Glycol-epoetin Beta)

NCT01974271 ·Status: COMPLETED

A Study of Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA)

NCT01194154 ·Status: COMPLETED ·Phase: PHASE2

A Study Of Mircera In Patients With Kidney Disease Who Are Not On Dialysis

NCT02490514 ·Status: COMPLETED

Study of the Efficacy and Safety of BCD-131 and Mircera® in the Treatment of Anemia in Patients With Chronic Kidney Disease on Dialysis

NCT07119372 ·Status: RECRUITING ·Phase: PHASE3

A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease

NCT05951192 ·Status: COMPLETED ·Phase: PHASE4

Observational Study of Methoxy Polyethylene Glycol Epoetin Beta Daily Use in Participants on Peritoneal Dialysis

NCT02596945 ·Status: COMPLETED

MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5

NCT01121237 ·Status: COMPLETED

An Observational Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) in Chronic Kidney Disease Participants on Dialysis

NCT02238080 ·Status: COMPLETED

Optimal Titration Regimen for SBR759 in Lowering Serum Phosphate Levels in Asian Chronic Kidney Disease Patients on Hemodialysis

NCT00704678 ·Status: COMPLETED ·Phase: PHASE2

A Clinical Study of Calderasib (MK-1084) in Participants With Renal Impairment (MK-1084-010)

NCT06814119 ·Status: COMPLETED ·Phase: PHASE1

Comparative Study of the Efficacy and Safety of BCD-131 and Mircera in Treatment of Anemia in CKD Patients on Dialysis

NCT03519243 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis

NCT00704483 ·Status: COMPLETED ·Phase: PHASE2

A Renal Impairment Study for PF-04965842

NCT03660241 ·Status: COMPLETED ·Phase: PHASE1

16-Week Repeat Oral Dose Study of AKB-6548 for Anemia in Participants With End Stage Renal Disease (ESRD) Requiring Chronic Hemodialysis

NCT02260193 ·Status: COMPLETED ·Phase: PHASE2

Study of GBT021601 in Participants With Renal Impairment

NCT05878704 ·Status: TERMINATED ·Phase: PHASE1

20-Week Repeat Oral Dose Study of AKB-6548 in Participants With Chronic Kidney Disease and Anemia

NCT01906489 ·Status: COMPLETED ·Phase: PHASE2

PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function

NCT04656795 ·Status: COMPLETED ·Phase: PHASE1

A Renal Impairment Study for PF-06651600

NCT04037865 ·Status: TERMINATED ·Phase: PHASE1

Study to Evaluate the Efficacy and Safety of GX-E2 in the Anemic Patients Diagnosed With Chronic Kidney Disease (CKD)

NCT02044653 ·Status: COMPLETED ·Phase: PHASE2

Renal Impairment Study of PF-06700841

NCT04260464 ·Status: COMPLETED ·Phase: PHASE1

Study of Intraperitoneal Triferic in Patients on Chronic Peritoneal Dialysis

NCT02909153 ·Status: COMPLETED ·Phase: PHASE1

Effects of Phosphate Binding With Sevelamer in Stage 3 Chronic Kidney Disease

NCT00806481 ·Status: COMPLETED ·Phase: PHASE2

Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients

NCT03303144 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function

NCT01419041 ·Status: COMPLETED ·Phase: PHASE1

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Renal Impairment Compared to Healthy Participants.

NCT05282030 ·Status: COMPLETED ·Phase: PHASE1